Plaque vulnerability at non-culprit lesions in obese patients with coronary artery disease: Frequency-domain optical coherence tomography analysis.

scientific article published on 31 July 2015

Plaque vulnerability at non-culprit lesions in obese patients with coronary artery disease: Frequency-domain optical coherence tomography analysis. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/2047487315598711
P698PubMed publication ID26232281

P50authorSteven NissenQ7615086
Samir KapadiaQ87699930
E. Murat TuzcuQ108198403
Stephen NichollsQ73438504
Bhanu DuggalQ83533227
P2093author name stringKiyoko Uno
Rishi Puri
Yu Kataoka
Muhammad Hammadah
P2860cites workEpidemiologic and economic consequences of the global epidemics of obesity and diabetesQ22251061
Concept of vulnerable/unstable plaqueQ27687028
Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control studyQ28280445
Prevalence and trends in obesity among US adults, 1999-2008Q29547759
Optical coherence tomographyQ29617481
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trialsQ29617910
Comprehensive volumetric optical microscopy in vivoQ30488753
Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interactionQ34216019
Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and ValidationQ34261694
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trialQ34501729
Update on acute coronary syndromes: the pathologists' viewQ34646452
Inflammation, insulin resistance, and obesity.Q35918777
Adipose tissue, inflammation, and cardiovascular diseaseQ36125401
Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissueQ36141342
Abdominal obesity and metabolic syndromeQ36682671
International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countriesQ36777590
Adipokines as emerging mediators of immune response and inflammation.Q37014112
Effect of obesity on coronary atherosclerosis and outcomes of percutaneous coronary intervention: grayscale and virtual histology intravascular ultrasound substudy of assessment of dual antiplatelet therapy with drug-eluting stentsQ38418337
Adiponectin, type 2 diabetes and cardiovascular riskQ44240418
Association of hypoadiponectinemia with impaired vasoreactivityQ44513155
Adiponectin stimulates production of nitric oxide in vascular endothelial cells.Q44565932
Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trialQ44783935
Intensive lipid lowering with atorvastatin in patients with stable coronary diseaseQ45310626
Disturbed adiponectin – AMPK system in skeletal muscle of patients with metabolic syndrome.Q46178402
Adiponectin inhibits endothelial synthesis of interleukin-8.Q46790564
Association between plasma high-molecular-weight adiponectin and coronary plaque characteristics assessed by computed tomography angiography in conditions of visceral adipose accumulationQ47315959
Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophagesQ47735588
Low plasma adiponectin levels are associated with presence of thin-cap fibroatheroma in men with stable coronary artery diseaseQ47917029
Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of CardiologyQ48575894
Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound.Q52545341
Effects of Obesity on Lipid-Lowering, Anti-Inflammatory, and Antiatherosclerotic Benefits of Atorvastatin or Pravastatin in Patients With Coronary Artery Disease (from the REVERSAL Study)Q57740273
P433issue10
P921main subjectobesityQ12174
coronary artery diseaseQ844935
P304page(s)1331-1339
P577publication date2015-07-31
P1433published inEuropean Journal of Preventive CardiologyQ2493290
P1476titlePlaque vulnerability at non-culprit lesions in obese patients with coronary artery disease: Frequency-domain optical coherence tomography analysis.
P478volume22

Reverse relations

cites work (P2860)
Q52675560Adipose-Derived Exosomes Exert Proatherogenic Effects by Regulating Macrophage Foam Cell Formation and Polarization.
Q33567290Lipid Lowering Therapy to Modify Plaque Microstructures.
Q46445382Omentin concentrations are independently associated with those of matrix metalloproteinase-3 in patients with mild but not severe rheumatoid arthritis
Q35997013Outcome after Elective Percutaneous Coronary Intervention Depends on Age in Patients with Stable Coronary Artery Disease - An Analysis of Relative Survival in a Multicenter Cohort and an OCT Substudy

Search more.